BackGreat Novel Therapeutics Biotech & Medicals Overview

Great Novel Therapeutics Biotech & Medicals Receivables

Track Great Novel Therapeutics Biotech & Medicals's receivables ($8.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$8.47M
↑ 1237.60% YoYΔ $7.83M vs prior year quarter

Peer trimmed avg / median

Loading

Great Novel Therapeutics Biotech & Medicals Receivables History

Loading

Great Novel Therapeutics Biotech & Medicals vs. peers: Receivables Comparison

Loading

Great Novel Therapeutics Biotech & Medicals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Great Novel Therapeutics Biotech & Medicals (7427.TWO) FAQ

The latest receivables for 7427.TWO is $8.5M as of June 2026. That compares with $630K in the prior-year period — up 1237.6% year over year. Investors often review this figure alongside Great Novel Therapeutics Biotech & Medicals's historical trend and sector peers before judging valuation or financial health.

Over the past year, 7427.TWO's receivables moved from $630K to $8.5M — a 1237.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Great Novel Therapeutics Biotech & Medicals's operating scale or balance-sheet position.

A receivables figure of $8.5M for 7427.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 7427.TWO's receivables ($8.5M), review year-over-year change from $630K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Great Novel Therapeutics Biotech & Medicals's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.